Actavis
Actavis[edit]
Actavis plc was a global pharmaceutical company that, after a series of mergers, became a part of the current company Allergan plc.

Overview[edit]
Originally based in Iceland, Actavis grew rapidly through both organic growth and acquisitions, eventually becoming one of the largest generic pharmaceutical companies in the world.
History[edit]
- 1956: Actavis was founded in Iceland as Pharmaco.
- 1999: The company was renamed Actavis following a merger.
- 2000s: Actavis experienced rapid growth and expansion, completing numerous acquisitions globally.
- 2015: Actavis completed the acquisition of Allergan, Inc., a transformative deal. Post-acquisition, the combined company adopted the name Allergan plc.
Notable Acquisitions[edit]
- Warner Chilcott: In 2013, Actavis acquired the specialty pharmaceutical company, enhancing its branded drug portfolio.
- Forest Laboratories: Acquired in 2014, this deal significantly expanded Actavis' branded drug business.
Key Products[edit]
Actavis had a vast product range that covered various therapeutic areas. Some of the most notable include:
- Generic formulations of blockbuster drugs.
- Specialty brand pharmaceuticals in areas such as women’s health, gastroenterology, and dermatology.
Facilities[edit]
Actavis had manufacturing, R&D, and commercial operations worldwide. Its facilities adhered to global quality standards and catered to both domestic and international markets.
Corporate Culture[edit]
Actavis was known for its dynamic culture, emphasizing innovation, growth, and a commitment to delivering high-quality pharmaceuticals to patients globally.
Controversies[edit]
The rapid growth of Actavis and its aggressive acquisition strategy did lead to certain criticisms, especially around issues of drug pricing and antitrust concerns.
See Also[edit]
References[edit]
- [1] "Actavis: Company History". Actavis Corporate Archive.
- [2] "Actavis and the Landscape of Generic Pharmaceuticals". Pharmaceutical Journal.
- [3] "Actavis Completes Allergan Acquisition". Financial Times.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
